News & Updates
Filter by Specialty:
Marine n-3 PUFAs do not affect incident PAD risk
Higher intake of marine n-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) exerts no significant protective effect against incident peripheral artery disease (PAD), a recent study has found.
Marine n-3 PUFAs do not affect incident PAD risk
16 Oct 2021
Hydroxychloroquine use does not increase risk of heart failure in RA patients
Use of hydroxychloroquine (HCQ) does not contribute to the development of heart failure (HF) in patients with rheumatoid arthritis (RA), a study has shown.
Hydroxychloroquine use does not increase risk of heart failure in RA patients
15 Oct 2021
Climbing stairs boosts vascular function in patient with hypertension
Climbing stairs is a simple method of assessing physical activity in patients with hypertension and may lead to improved vascular function, a recent study has found.
Climbing stairs boosts vascular function in patient with hypertension
14 Oct 2021
Dapagliflozin improves symptoms, physical limitations in HFpEF
Patients with heart failure and preserved ejection fraction (HFpEF) treated with dapagliflozin experienced improvements in symptoms and physical limitations, according to results of the PRESERVED-HF study presented at HFSA 2021.